Ondansetron

Manufacturer:

A-S Medication Solutions

Name:

Ondansetron

HCPCS Code Descriptor:

Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen

Category:

Q Code

HCPCS:

Q0162

NDC(s):

68462-0157-13, 68462-0158-11, 68462-0158-13, 68462-0106-30, 68462-0105-30, 68001-0247-17, 68001-0247-04, 68001-0246-17, 68001-0246-04, 67877-0170-30, 67877-0169-30, 55111-0154-30, 55111-0153-30, 51672-4091-03, 50090-4632-00, 50090-3178-04, 50090-3178-05, 50090-3178-02, 50090-3178-00, 50090-3178-01, 50090-1201-00, 50090-1200-02, 50090-1200-01, 50090-1200-00, 16714-0671-02, 16714-0201-30, 16714-0201-10, 16714-0200-30, 16714-0160-01, 16714-0159-01, 00904-7073-93, 00904-6552-61, 00904-6551-61, 00781-5239-80, 00781-5238-64, 00781-5239-64, 00781-1681-31, 00781-1681-33, 00378-7734-97, 00378-7734-93, 00378-7732-93

Primary Type:

Oncology-Anti-Emetic

Generic Status:

Multi-Source

Route of Administration:

Oral

About:

Ondansetron is an Oncology-Anti-Emetic drug manufactured by A-S Medication Solutions and administered via the Oral route of administration. The Q Code: Q0162 is aligned to the drug Ondansetron.